DAX24.038 -0,8%ESt505.378 -0,7%Top 10 Crypto14,30 -1,4%Dow42.099 -0,6%Nas19.101 -0,5%Bitcoin95.737 -0,2%Euro1,1244 -0,5%Öl65,86 +1,4%Gold3.271 -0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 HENSOLDT HAG000 Tesla A1CX3T BYD A0M4W9 Siemens Energy ENER6Y Lufthansa 823212 D-Wave Quantum A3DSV9 thyssenkrupp 750000 Deutsche Bank 514000 Bayer BAY001 BASF BASF11 Commerzbank CBK100 Daimler Truck DTR0CK
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach NVIDIA-Zahlen: Asiens Börsen freundlich -- NVIDIA übertrifft Erwartungen -- Salesforce verdient mehr als erwartet
Top News
NVIDIA-Aktie legt zu: NVIDIA kann selbst die höchsten Erwartungen übertreffen NVIDIA-Aktie legt zu: NVIDIA kann selbst die höchsten Erwartungen übertreffen
Hang Seng-Titel China Petroleum Chemical (Sinopec)-Aktie: China Petroleum Chemical (Sinopec) schüttet weniger Dividende aus Hang Seng-Titel China Petroleum Chemical (Sinopec)-Aktie: China Petroleum Chemical (Sinopec) schüttet weniger Dividende aus
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Kodiak Sciences Aktie

Handeln
Aktien-Sparplan anlegen
3,09 EUR -1,86 EUR -37,53 %
STU
3,51 USD -0,07 USD -1,96 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.167,99 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6P0

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS50015M1099

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolKOD

Kodiak Sciences Aktien News

DatumMeistgelesen
PR NewswireKodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results
PR NewswireKodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases
ZacksDown -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)
Wer­bungKodiak Sciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireKodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
PR NewswireKodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
PR NewswireKodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025
PR NewswireKodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
BenzingaPactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday
BenzingaEye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock
ZacksKodiak Sciences Inc. (KOD) Just Flashed Golden Cross Signal: Do You Buy?
PR NewswireKodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results
PR NewswireKodiak Sciences to Participate in Upcoming Investor Conferences
PR NewswireKodiak Sciences to Present at Innovate Retina 2024
PR NewswireKodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time
PR NewswireKodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City
ZacksWhy Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report?
PR NewswireKodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results
ZacksAll You Need to Know About Kodiak Sciences (KOD) Rating Upgrade to Buy
ZacksShould You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
ZacksWhy Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
PR NewswireKodiak Sciences to Present at Upcoming Investor and Clinical Conferences
PR NewswireKodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
PR NewswireKodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
PR NewswireKodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Co...
PR NewswireKodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
PR NewswireKodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024
PR NewswireKodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting
PR NewswireKodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireKodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
PR NewswireKodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights
PR NewswireKodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regul...
PR NewswireKODIAK SCIENCES ANNOUNCES FIRST TIME PRESENTATION OF PRIMARY ENDPOINT DATA FROM TARCOCIMAB TEDROMER PHASE 3 GLOW STUDY IN PATIENTS WITH DIABETIC RETINOPATHY AT AMERICAN ACADEMY OF OPHTHALMOLOGY AN...
PR NewswireKodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society
PR NewswireKodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
PR NewswireNew one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vei...
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD
PR NewswireKodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kodiak Sciences Inc. - KOD
Wer­bung

Kodiak Sciences News

Kodiak Sciences News: auf dieser Seite finden Sie alle Kodiak Sciences News und Nachrichten zur Kodiak Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Kodiak Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Kodiak Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.